Quorum Biotech Private Limited
About Quorum Biotech Private Limited
Data last updated:
Quorum Biotech Private Limited is a private limited company based in Delhi, India, a subsidiary of Sugriva Jankalyan Foundation. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 September 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2009PTC193814.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Amar Chitrakar and Suparna Chitrakar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R – 122 G/F Old – 22A Gali No – 10 Ph – 2, Shiv Vihar Karwal Nagar, Delhi, India – 110094.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.09 Cr, a decline of 24% compared to the previous year. For the same year it recorded a net profit of ₹63,151 (net margin 0.6%) and EBITDA of ₹85,330 (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 635% over three years and 236% over five years.
Its group structure includes 1 subsidiary.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Quorum Biotech Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressR – 122 G/F Old – 22A Gali No – 10 Ph – 2, Shiv Vihar Karwal Nagar, Delhi, India – 110094
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Quorum Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Quorum Biotech Private Limited
FY 2025 filings availableQuorum Biotech Private Limited reported revenue of ₹1.09 Cr (down 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 24% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 236%. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹85,330 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹63,151 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Quorum Biotech Private Limited, buy the company report.
Board of directors of Quorum Biotech Private Limited
Quorum Biotech has 2 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amar Chitrakar Also directs: Abhigam Tradecom Private Limited, Feastlo Enterprises Private Limited, Khatushyam Multitrades Private Limited and 5 more | Director | 10 Jan 2024 | 2 Years 9 Months | Current |
| Suparna Chitrakar Also directs: Abhigam Tradecom Private Limited, Feastlo Enterprises Private Limited, Khatushyam Multitrades Private Limited and 5 more | Director | 10 Jan 2024 | 2 Years 9 Months | Current |
Peer comparison
Quorum Biotech Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Giselbert Private Limited | ₹1.09 Cr (FY 2025) | 1815.0% | Narendranagar, Uttarakhand, India | |||
| Deo Pharmaceuticals Private Limited | ₹1.09 Cr (FY 2024) | 53.0% | Chennai, Tamil Nadu, India | |||
| Shiv Herbal Limited | ₹1.09 Cr (FY 2025) | 39.0% | Nagpur, Maharashtra, India | |||
| Uni Biotech Healthcare Private Limited | ₹1.09 Cr (FY 2024) | -16.0% | Panchkula, Haryana, India | |||
| Bora Pharma Private Limited | ₹1.09 Cr (FY 2024) | -15.0% | Ahmednagar, Maharashtra, India | |||
| Quorum Biotech Private Limitedthis company | ₹1.09 Cr (FY 2025) | ₹63,151 | 0.6% | -24.0% | Delhi, India | |
| Scoria Pharmaceuticals Private Limited | ₹1.09 Cr (FY 2025) | -10.0% | New Delhi, Delhi, India | |||
| Dominant Pharma Private Limited | ₹1.08 Cr (FY 2025) | 21.0% | Vadodara, Gujarat, India | |||
| Vyankatesh Medicare Private Limited | ₹1.08 Cr (FY 2025) | -27.0% | Nagpur, Maharashtra, India | |||
| Chaplet Pharmaceutical Private Limited | ₹1.08 Cr (FY 2025) | 7.0% | New Delhi, Delhi, India | |||
| Masttree Formulations Private Limited | ₹1.08 Cr (FY 2024) | 178.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Quorum Biotech Private Limited, buy the company report.
Auditor
Quorum Biotech Private Limited is audited by BANSAL NAVEEN & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BANSAL NAVEEN & ASSOCIATES | FY 2019 | 031425N |
Shareholding
The shareholding of Quorum Biotech Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Quorum Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Quorum Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Quorum Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Quorum Biotech has 1 subsidiary company. This group structure data is as of FY 2019. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Ex Maxsale Marketing Private Limited | U51909DL2003PTC121353 |
To see the full group structure of Quorum Biotech Private Limited, buy the company report.
GST
No GST registration is on our record for Quorum Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Quorum Biotech Private Limited has 15 board changes on record since 2009: 2 appointments and 13 cessations. The latest: Payal Sharma ceased to be Director on 11 Jan 2024.
6 earlier events are in the company report.
Frequently asked questions
Quorum Biotech is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 September 2009 (17+ years old) and is registered under CIN U24100DL2009PTC193814.
Quorum Biotech has 2 current directors:
- Amar Chitrakar - Director
- Suparna Chitrakar - Director
The latest financial statements of Quorum Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Quorum Biotech is U24100DL2009PTC193814. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Quorum Biotech was incorporated on 02 September 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Quorum Biotech by revenue are Giselbert Private Limited, Deo Pharmaceuticals Private Limited, Shiv Herbal Limited, Uni Biotech Healthcare Private Limited, Bora Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Payal Sharma ceased to be Director on 11 Jan 2024. Sunny Sharma ceased to be Director on 11 Jan 2024. Amar Chitrakar was appointed as Director on 10 Jan 2024. Quorum Biotech has 15 board changes on record in total.
The registered office of Quorum Biotech is at R – 122 GF Old – 22A Gali No – 10 Ph – 2, Shiv Vihar Karwal Nagar, Delhi, India – 110094.
Quorum Biotech operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Quorum Biotech is compliant as of 06 September 2026. The company is actively filing with the Registrar of Companies.
Quorum Biotech has 1 subsidiary company including Ex Maxsale Marketing Private Limited.